International Isotopes, Inc. engages in the manufacture of nuclear medicine calibration and reference standards cobalt tele therapy sources, as well as radioisotopes and radiochemical for medical research and clinical devices. It operates through the following segments: Radiochemical Products, Cobalt Products, Nuclear Medicine Products, Radiological Services and Fluorine Products. The Radiochemical Products segment includes production and distribution of various isotopically pure radio chemicals for medical, industrial, or research applications. The Cobalt Products segment includes management of a cobalt irradiation contract, fabrication of cobalt capsules for tele therapy or irradiation devices, and recycling of expended cobalt sources. The Nuclear Medicine Products segment consists of the manufacture of sources and standards associated with Single Photon Emission Computed Tomography imaging, patient positioning, and calibration or operational testing of dose measuring equipment for the nuclear pharmacy industry. Radiological Services Segment concerns a wide array of miscellaneous services that consists of gemstone processing and field services that include source installation, removal, and radiation device decommissioning. The Fluorine Product segment involved the production of small scale qualification samples of high purity fluoride gas for various industrial applications, as well as development of laboratory and analytical processes required to support the planned uranium de-conversion and fluorine extraction facility. International Isotopes was founded in November 1995 and is headquartered in Idaho Falls, ID.
Company profile
Ticker
INIS
Exchange
Website
CEO
Steve T. Laflin
Employees
Incorporated
Location
Fiscal year end
Sector
Industry (SIC)
Danaher • Fortive • Roper • Ametek • Sensata Technologies Holding • Keysight • MKS Instruments • Cognex • Rudolph • Sypris Solutions ...
SEC CIK
Corporate docs
IRS number
742763837
INIS stock data
Investment data
Securities sold
Number of investors
Calendar
16 May 22
2 Jul 22
31 Dec 22
Financial summary
Quarter (USD) | Mar 22 | Dec 21 | Sep 21 | Jun 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | Dec 19 | Dec 18 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 3.97M | 3.97M | 3.97M | 3.97M | 3.97M | 3.97M |
Cash burn (monthly) | (no burn) | (no burn) | 125.35K | 50.53K | 285.96K | 60.54K |
Cash used (since last report) | n/a | n/a | 384.21K | 154.87K | 876.5K | 185.57K |
Cash remaining | n/a | n/a | 3.58M | 3.81M | 3.09M | 3.78M |
Runway (months of cash) | n/a | n/a | 28.6 | 75.5 | 10.8 | 62.5 |
Recent insider trades
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
21 Feb 22 | Steve Laflin | Stock Option Common Stock | Grant | Acquire A | No | No | 0.09 | 2,000,000 | 180K | 2,000,000 |
21 Feb 22 | Robert Atcher | Stock Option Common Stock | Grant | Acquire A | No | No | 0.09 | 2,000,000 | 180K | 2,000,000 |
21 Feb 22 | W Matthew Cox | Stock Option Common Stock | Grant | Acquire A | No | No | 0.09 | 1,000,000 | 90K | 1,000,000 |
21 Feb 22 | Christopher G Grosso | Stock Option Common Stock | Grant | Acquire A | No | No | 0.09 | 2,000,000 | 180K | 2,000,000 |
20 Jan 21 | W Matthew Cox | Common Stock | Payment of exercise | Dispose F | No | No | 0.28 | 13,393 | 3.75K | 49,107 |
20 Jan 21 | W Matthew Cox | Common Stock | Option exercise | Acquire M | No | No | 0.06 | 62,500 | 3.75K | 62,500 |
20 Jan 21 | W Matthew Cox | Stock Option Common Stock | Option exercise | Dispose M | No | No | 0.06 | 62,500 | 3.75K | 187,500 |
Institutional ownership, Q4 2021
45.4% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 1 |
Opened positions | 0 |
Closed positions | 1 |
Increased positions | 0 |
Reduced positions | 1 |
13F shares | Current |
---|---|
Total value | 21.59M |
Total shares | 229.63M |
Total puts | 0 |
Total calls | 0 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Kennerman Associates | 229.63M | $21.59M |
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
advertising, announced, Committee, competitor, discontinued, disposal, drastically, European, fulfilled, half, installation, longer, merged, minimal, Pharmalogic, point, respectfully, sell, separately, short, sublease, unable, unexercised, waste
Removed:
ability, accommodate, achieve, adequate, administered, Administration, Administrative, Aid, Anderson, applicable, ASC, assumed, borrow, breached, carrying, cesium, charge, claim, cleanup, Consulting, contamination, continuing, converted, corporate, corrective, delivered, delivery, Economic, eliminating, event, filing, final, General, growth, heightened, indemnification, indemnified, investment, involved, involving, KeyBank, lender, light, loan, location, matter, month, notification, onsite, outbreak, ownership, PAA, Paycheck, paying, pipeline, PPP, prepaid, procure, profitability, Program, projection, Protection, Reconciliation, recovery, reduce, refund, reimburse, relation, Relief, renegotiated, repay, request, requested, SBA, scheduled, secure, settlement, shown, Small, stopped, team, uncertainty, Washington, wrapping
Financial reports
Current reports
8-K
Completion of Acquisition or Disposition of Assets
22 Feb 22
8-K
Entry into a Material Definitive Agreement
16 Feb 22
8-K
International Isotopes Inc. Announces It Has
14 Jul 21
8-K
Termination of a Material Definitive Agreement
28 Dec 20
8-K
Departure of Directors or Certain Officers
21 Jul 20
8-K
Entry into a Material Definitive Agreement
29 Apr 20
8-K
International Isotopes Inc.Announces
13 Feb 20
8-K
Entry into a Material Definitive Agreement
6 Jan 20
8-K
Departure of Directors or Certain Officers
27 Sep 19
8-K
Submission of Matters to a Vote of Security Holders
18 Jul 19
Registration and prospectus
S-8
Registration of securities for employees
9 Feb 21
S-8
Registration of securities for employees
14 Nov 18
D
$6M in equity / options, sold $3.43M, 37 investors
2 Mar 17
S-8
Registration of securities for employees
13 Aug 15
D
$8M in equity / debt / options, sold $3.07M, 47 investors
6 Aug 12
424B3
Prospectus supplement
9 Jan 12
424B3
Prospectus supplement
14 Nov 11
424B3
Prospectus supplement
4 Oct 11
424B3
Prospectus supplement
13 Sep 11
424B3
Prospectus supplement
9 Aug 11
Other
CT ORDER
Confidential treatment order
21 May 17
CT ORDER
Confidential treatment order
4 Oct 15
CT ORDER
Confidential treatment order
26 May 15
CT ORDER
Confidential treatment order
16 May 12
EFFECT
Notice of effectiveness
19 Jul 11
CORRESP
Correspondence with SEC
4 Jul 11
CORRESP
Correspondence with SEC
4 Jul 11
UPLOAD
Letter from SEC
22 Jun 11
CORRESP
Correspondence with SEC
30 May 11
CORRESP
Correspondence with SEC
30 May 11
Ownership
SC 13G/A
INTERNATIONAL ISOTOPES / Kennerman Associates ownership change
2 May 22
4
INTERNATIONAL ISOTOPES / Steve Laflin ownership change
23 Feb 22
4
INTERNATIONAL ISOTOPES / Robert Atcher ownership change
23 Feb 22
4
INTERNATIONAL ISOTOPES / W MATTHEW COX ownership change
23 Feb 22
4
INTERNATIONAL ISOTOPES / CHRISTOPHER G GROSSO ownership change
23 Feb 22
4
INTERNATIONAL ISOTOPES / W MATTHEW COX ownership change
30 Apr 21
4
INTERNATIONAL ISOTOPES / CHRISTOPHER G GROSSO ownership change
30 Apr 21
4
INTERNATIONAL ISOTOPES / RALPH M RICHART ownership change
30 Apr 21
4
INTERNATIONAL ISOTOPES / Steve Laflin ownership change
30 Apr 21
SC 13G/A
INTERNATIONAL ISOTOPES / Kennerman Associates ownership change
30 Apr 21